GB201702551D0 - Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage - Google Patents

Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage

Info

Publication number: GB201702551D0
Authority: GB; United Kingdom
Prior art keywords: neurodegenerative diseases; lysosomal storage; defects; therapeutic agents; diseases associated
Prior art date: 2017-02-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1702551.1A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Intrabio Ltd

Original Assignee

Intrabio Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-02-16

Filing date

2017-02-16

Publication date

2017-04-05

2017-02-16 Application filed by Intrabio Ltd filed Critical Intrabio Ltd

2017-02-16 Priority to GBGB1702551.1A priority Critical patent/GB201702551D0/en

2017-04-05 Publication of GB201702551D0 publication Critical patent/GB201702551D0/en

2017-08-11 Priority to MA43828A priority patent/MA43828B1/en

2017-08-11 Priority to HUE17767934A priority patent/HUE045043T2/en

2017-08-11 Priority to RU2021128045A priority patent/RU2849887C2/en

2017-08-11 Priority to PCT/IB2017/054929 priority patent/WO2018029658A1/en

2017-08-11 Priority to US16/324,353 priority patent/US12144792B2/en

2017-08-11 Priority to MX2019001575A priority patent/MX383499B/en

2017-08-11 Priority to CN202511449973.8A priority patent/CN121081445A/en

2017-08-11 Priority to SI201730071T priority patent/SI3416631T1/en

2017-08-11 Priority to TNP/2019/000033A priority patent/TN2019000033A1/en

2017-08-11 Priority to CN201780059708.6A priority patent/CN109789114A/en

2017-08-11 Priority to EP24191483.7A priority patent/EP4467195A3/en

2017-08-11 Priority to LTEP17767934.7T priority patent/LT3416631T/en

2017-08-11 Priority to KR1020257008819A priority patent/KR20250042197A/en

2017-08-11 Priority to CN202310627214.0A priority patent/CN116459244A/en

2017-08-11 Priority to SM20190370T priority patent/SMT201900370T1/en

2017-08-11 Priority to MA047521A priority patent/MA47521A/en

2017-08-11 Priority to DK17767934.7T priority patent/DK3416631T3/en

2017-08-11 Priority to BR112019002730-0A priority patent/BR112019002730A2/en

2017-08-11 Priority to PL17767934T priority patent/PL3416631T3/en

2017-08-11 Priority to KR1020227021012A priority patent/KR20220093385A/en

2017-08-11 Priority to RS20190801A priority patent/RS59048B1/en

2017-08-11 Priority to IL310799A priority patent/IL310799A/en

2017-08-11 Priority to AU2017308865A priority patent/AU2017308865B2/en

2017-08-11 Priority to CN202310629563.6A priority patent/CN116492328A/en

2017-08-11 Priority to KR1020197007032A priority patent/KR102413756B1/en

2017-08-11 Priority to PT17767934T priority patent/PT3416631T/en

2017-08-11 Priority to EP17767934.7A priority patent/EP3416631B1/en

2017-08-11 Priority to RU2019106506A priority patent/RU2756519C2/en

2017-08-11 Priority to MDE20190027T priority patent/MD3416631T2/en

2017-08-11 Priority to CA3033564A priority patent/CA3033564A1/en

2017-08-11 Priority to MEP-2019-169A priority patent/ME03454B/en

2017-08-11 Priority to EP19174007.5A priority patent/EP3583940A1/en

2017-08-11 Priority to IL310801A priority patent/IL310801A/en

2017-08-11 Priority to HRP20191055TT priority patent/HRP20191055T1/en

2017-08-11 Priority to ES17767934T priority patent/ES2733677T3/en

2017-08-11 Priority to SG11201901063SA priority patent/SG11201901063SA/en

2017-08-11 Priority to IL264641A priority patent/IL264641B2/en

2017-08-11 Priority to JP2019507819A priority patent/JP6957602B2/en

2017-08-11 Priority to KR1020247014635A priority patent/KR102785448B1/en

2019-02-07 Priority to MX2021006901A priority patent/MX2021006901A/en

2019-07-16 Priority to CY20191100759T priority patent/CY1121930T1/en

2021-10-06 Priority to JP2021164793A priority patent/JP2022003085A/en

2023-03-15 Priority to US18/183,972 priority patent/US20230210799A1/en

2023-04-05 Priority to AU2023202121A priority patent/AU2023202121B2/en

2023-09-08 Priority to JP2023146465A priority patent/JP2023175762A/en

2024-01-12 Priority to US18/411,512 priority patent/US20240189267A1/en

2024-04-11 Priority to MX2024004439A priority patent/MX2024004439A/en

2025-03-21 Priority to AU2025202077A priority patent/AU2025202077A1/en

Status Ceased legal-status Critical Current

Links

230000004770 neurodegeneration Effects 0.000 title 2
208000015122 neurodegenerative disease Diseases 0.000 title 2
208000015439 Lysosomal storage disease Diseases 0.000 title 1
230000007547 defect Effects 0.000 title 1
239000003814 drug Substances 0.000 title 1
230000002132 lysosomal effect Effects 0.000 title 1
229940124597 therapeutic agent Drugs 0.000 title 1

GBGB1702551.1A 2016-08-11 2017-02-16 Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage Ceased GB201702551D0 (en)

Priority Applications (49)

Application Number	Priority Date	Filing Date	Title
GBGB1702551.1A GB201702551D0 (en)	2017-02-16	2017-02-16	Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage
MA43828A MA43828B1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
HUE17767934A HUE045043T2 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
RU2021128045A RU2849887C2 (en)	2016-08-11	2017-08-11	Therapeutic agents against neurodegenerative diseases
PCT/IB2017/054929 WO2018029658A1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
US16/324,353 US12144792B2 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
MX2019001575A MX383499B (en)	2016-08-11	2017-08-11	THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES
CN202511449973.8A CN121081445A (en)	2016-08-11	2017-08-11	Treatment agents for neurodegenerative diseases
SI201730071T SI3416631T1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
TNP/2019/000033A TN2019000033A1 (en)	2016-08-11	2017-08-11	THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES
CN201780059708.6A CN109789114A (en)	2016-08-11	2017-08-11	Therapeutic agent for neurodegenerative disease
EP24191483.7A EP4467195A3 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
LTEP17767934.7T LT3416631T (en)	2016-08-11	2017-08-11	THERAPEUTIC AGENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
KR1020257008819A KR20250042197A (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
CN202310627214.0A CN116459244A (en)	2016-08-11	2017-08-11	Therapeutics for Neurodegenerative Diseases
SM20190370T SMT201900370T1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
MA047521A MA47521A (en)	2016-08-11	2017-08-11	THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES
DK17767934.7T DK3416631T3 (en)	2016-08-11	2017-08-11	THERAPEUTIC SUBSTANCES FOR NEURODEGENERATIVE DISEASES
BR112019002730-0A BR112019002730A2 (en)	2016-08-11	2017-08-11	acetyl leucine, or a pharmaceutically acceptable salt thereof, for use in a method of treating a neurodegenative disease
PL17767934T PL3416631T3 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
KR1020227021012A KR20220093385A (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
RS20190801A RS59048B1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
IL310799A IL310799A (en)	2016-08-11	2017-08-11	Acetyl-leucine for use in the treatment of neurodegenerative diseases
AU2017308865A AU2017308865B2 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
CN202310629563.6A CN116492328A (en)	2016-08-11	2017-08-11	Therapeutics for Neurodegenerative Diseases
KR1020197007032A KR102413756B1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
PT17767934T PT3416631T (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
EP17767934.7A EP3416631B1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
RU2019106506A RU2756519C2 (en)	2016-08-11	2017-08-11	Therapeutic agents against neurodegenerative diseases
MDE20190027T MD3416631T2 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
CA3033564A CA3033564A1 (en)	2016-08-11	2017-08-11	Acetyl-leucine for neurodegenerative diseases
MEP-2019-169A ME03454B (en)	2016-08-11	2017-08-11	THERAPEUTIC FOR NEURODEGENERATIVE DISEASES
EP19174007.5A EP3583940A1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
IL310801A IL310801A (en)	2016-08-11	2017-08-11	Acetyl-leucine for use in treating neurodegenerative diseases
HRP20191055TT HRP20191055T1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
ES17767934T ES2733677T3 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
SG11201901063SA SG11201901063SA (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
IL264641A IL264641B2 (en)	2016-08-11	2017-08-11	Acetyl-leucine for use in treating neurodegenerative diseases
JP2019507819A JP6957602B2 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
KR1020247014635A KR102785448B1 (en)	2016-08-11	2017-08-11	Therapeutic agents for neurodegenerative diseases
MX2021006901A MX2021006901A (en)	2016-08-11	2019-02-07	Therapeutic agents for neurodegenerative diseases.
CY20191100759T CY1121930T1 (en)	2016-08-11	2019-07-16	THERAPEUTIC AGENTS FOR NEURODEGENERATE DISEASES
JP2021164793A JP2022003085A (en)	2016-08-11	2021-10-06	Therapeutic agents for neurodegenerative diseases
US18/183,972 US20230210799A1 (en)	2016-08-11	2023-03-15	Therapeutic agents for neurodegenerative diseases
AU2023202121A AU2023202121B2 (en)	2016-08-11	2023-04-05	Therapeutic agents for neurodegenerative diseases
JP2023146465A JP2023175762A (en)	2016-08-11	2023-09-08	Therapies for neurodegenerative diseases
US18/411,512 US20240189267A1 (en)	2016-08-11	2024-01-12	Therapeutic agents for neurodegenerative diseases
MX2024004439A MX2024004439A (en)	2016-08-11	2024-04-11	Therapeutic agents for neurodegenerative diseases
AU2025202077A AU2025202077A1 (en)	2016-08-11	2025-03-21	Therapeutic agents for neurodegenerative diseases

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1702551.1A GB201702551D0 (en)	2017-02-16	2017-02-16	Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage

Publications (1)

Publication Number	Publication Date
GB201702551D0 true GB201702551D0 (en)	2017-04-05

Family

ID=58486850

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1702551.1A Ceased GB201702551D0 (en)	2016-08-11	2017-02-16	Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage

Country Status (1)

Country	Link
GB (1)	GB201702551D0 (en)

2017
- 2017-02-16 GB GBGB1702551.1A patent/GB201702551D0/en not_active Ceased

Publication	Publication Date	Title
IL267685A (en)	2019-08-29	Method for modulating inflammasome activity and inflammation in the lung
IL256687B (en)	2022-02-01	Isolated tau-binding antibody and use thereof in therapy and diagnosis
GB201507721D0 (en)	2015-06-17	Immunosuppressive agents and their use in therapy
GB201604213D0 (en)	2016-04-27	Drug combination and its use in therapy
IL257820A (en)	2018-04-30	Aminoglycoside derivatives and uses thereof in treating genetic disorders
SI3157522T1 (en)	2020-01-31	Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses
IL249485B (en)	2018-07-31	O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated with an accumulation of misfolded proteins
IL285304A (en)	2021-09-30	Methods for treating symptoms and disorders associated with lysosomal storage diseases
IL246855A0 (en)	2016-08-31	Agents for use in the treatment of retinal inflammation
IL248854B (en)	2020-05-31	(r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
EP3291818A4 (en)	2018-12-12	Compositions and methods for delivering therapeutic agents into the colon
ZA201608558B (en)	2018-05-30	Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
IL267534A (en)	2019-08-29	Low dose drug combinations for use in preventing and treating neuronal damage
ZA201900707B (en)	2022-04-28	New treatment for the non alcoholic steatohepatitis and fibrosis
EP3162377A4 (en)	2018-03-14	Use of -asarone in preparing drugs for preventing and treating alzheimer's disease
GB201813011D0 (en)	2018-09-26	Means and methods for drought tolerance in crops
GB201706867D0 (en)	2017-06-14	Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage
GB201705766D0 (en)	2017-05-24	Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage
GB201702551D0 (en)	2017-04-05	Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage
GB201613829D0 (en)	2016-09-28	Therapeutic agents for neurodegenerative diseases, lysosomal storage disorders and neurodegenerative diseases associated with defects in lysosomal storage
GB201615844D0 (en)	2016-11-02	Agents for use in therapy
GB201706854D0 (en)	2017-06-14	Therapeutic agents for lysosomal storage disorders
GB201705762D0 (en)	2017-05-24	Therapeutic agents for lysosomal storage disorders
GB201702552D0 (en)	2017-04-05	Therapeutic agents for lysosomal storage disorders
GB201613828D0 (en)	2016-09-28	Therapeutic agents for lysosomal storage disorders

Legal Events

Date	Code	Title	Description
2018-01-10	AT	Applications terminated before publication under section 16(1)